EarliTec Diagnostics, Inc.

📍 Atlanta, United States🗓 Founded 2019👥 30 employees💰 Last funded Jul 2024
EarliTec Diagnostics is making earlier identification and treatment for autism and related early childhood vulnerabilities accessible to children everywhere. EarliTecs flagship product, EarliPoint™, is FDA authorized to diagnose and assess autism in children ages 16-30 months old and is available now.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2019
Founded
Investor geography1 country
United States
1
Frequently asked questions
Who invested in EarliTec Diagnostics, Inc.?
EarliTec Diagnostics, Inc. has 1 investors on record on gritt.io, 1 mid-stage.
When did EarliTec Diagnostics, Inc. last raise funding?
The most recent investment in EarliTec Diagnostics, Inc. recorded on gritt.io was in July 2024.
When was EarliTec Diagnostics, Inc. founded?
EarliTec Diagnostics, Inc. was founded in 2019.
What industry is EarliTec Diagnostics, Inc. in?
EarliTec Diagnostics, Inc. operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is EarliTec Diagnostics, Inc. based?
EarliTec Diagnostics, Inc. is headquartered in Atlanta, United States.